focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Notice of Interim Results

21 Sep 2011 09:00

RNS Number : 6185O
e-Therapeutics plc
21 September 2011
 



 

 

e-Therapeutics plc

 

Notice of Interim Results

 

 

e-Therapeutics plc (AIM: ETX), the drug discovery and development company, will be announcing its interim results for the six months ended 31st July 2011 on Wednesday 19th October 2011.

 

-Ends-

 

 

For more information, please contact:

 

e-Therapeutics plc

Malcolm Young / Daniel Elger

Tel: +44 (0) 191 233 1317 / Tel: +44 (0) 7909 915 068

www.etherapeutics.co.uk 

 

Panmure Gordon (UK) Limited

Andrew Burnett / Aubrey Powell

Tel: +44 (0) 20 7459 3600

www.panmure.com

 

College Hill

Melanie Toyne Sewell/Jayne Crook

Tel: +44 (0) 20 7457 2020

Email: e-therapeutics@collegehill.com

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NORSEWFWSFFSEDU

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.